Rivastigmine Transdermal Patch: In the Treatment of Dementia of the Alzheimer's Type

Author： Yang Lily P.H. Keating Gillian M.

ISSN： 1172-7047

Source： CNS Drugs, Vol.21, Iss.11, 2007-01, pp. : 957-965

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Rivastigmine Transdermal Patch†: In Dementia of the Alzheimer's Type

By Dhillon Sohita

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 927-930

Adis International

Access to resources Recommend Favorite

Rivastigmine transdermal patch: a guide to its use in dementia of the Alzheimer's type

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 4, 2008-04 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Rivastigmine Transdermal Patch: A Review of its Use in the Management of Dementia of the Alzheimer's Type

By Dhillon Sohita

Drugs, Vol. 71, Iss. 9, 2011-06 ,pp. : 1209-1231

Adis International

Access to resources Recommend Favorite

Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease

By Cummings Jeffrey L.

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 41-49

Adis International

Access to resources Recommend Favorite

Estimation of the Absolute Bioavailability of Rivastigmine in Patients with Mild to Moderate Dementia of the Alzheimers Type

By Hossain M.

Clinical Pharmacokinetics, Vol. 41, Iss. 3, 2002-01 ,pp. : 225-234

Adis International

Access to resources Recommend Favorite